2751 - 2800 of 8620 Results
Title
Year
-
OPENTitle: Everyday Action Impairment in Parkinson's Disease DementiaJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 18Issue #: 5Start Page: 787End Page: 798Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s135561771200046xCitation Count: 45
-
OPENTitle: Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological StudyJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 4Start Page: 322End Page: 331Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5729910Citation Count: 19
-
OPENTitle: Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 24Issue #: 3Start Page: 269End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717001011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5820218Citation Count: 19
-
OPENTitle: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 responseJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 102Issue #: 4Start Page: 1093End Page: 1102Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rrBest OA location URL: https://jlb.onlinelibrary.wiley.com/doi/pdfdirect/10.1189/jlb.1A0417-147RRCitation Count: 30
-
OPENTitle: Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)Journal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 52Issue #: 14Start Page: 4115End Page: 4118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm9005065Best OA location URL: http://doi.org/10.1021/jm9005065Citation Count: 80
-
OPENTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm100027pBest OA location URL: https://doi.org/10.7270/q2dr2vqfCitation Count: 84
-
OPENTitle: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 51Issue #: 18Start Page: 5506End Page: 5521Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm8002153Best OA location URL: https://doi.org/10.7270/q2pz59qhCitation Count: 26
-
OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qCitation Count: 59
-
OPENTitle: Structure–Activity Relationship of N,N′-Disubstituted Pyrimidinetriones as CaV1.3 Calcium Channel-Selective Antagonists for Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 56Issue #: 11Start Page: 4786End Page: 4797Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm4005048Best OA location URL: http://doi.org/10.1021/jm4005048Citation Count: 30
-
OPENTitle: Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in RatsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 1106End Page: 1110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm101271sCitation Count: 48
-
OPENTitle: Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced ToxicityJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 368Issue #: 4Start Page: 1132End Page: 1144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2007.02.089Best OA location URL: http://doi.org/10.1016/j.jmb.2007.02.089Citation Count: 151
-
OPENTitle: 7T MRI subthalamic nucleus atlas for use with 3T MRIJournal Name: Journal of Medical ImagingPublisher: SPIE-Intl Soc Optical EngVol: 5Issue #: 01Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/1.jmi.5.1.015002Best OA location URL: https://www.spiedigitallibrary.org/journals/journal-of-medical-imaging/volume-5/issue-1/015002/7T-MRI-subthalamic-nucleus-atlas-for-use-with-3T-MRI/10.1117/1.JMI.5.1.015002.pdfCitation Count: 16
-
OPENTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Citation Count: 123
-
OPENTitle: LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell modelsJournal Name: Journal of Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 91Issue #: 4Start Page: 513End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00109-012-0984-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00109-012-0984-y.pdfCitation Count: 74
-
OPENTitle: Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSAJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 115Issue #: 7Start Page: 1001End Page: 1009Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-008-0030-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-008-0030-y.pdfCitation Count: 249
- A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia2013OPENTitle: A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystoniaJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 12Start Page: 1699End Page: 1707Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-1048-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-1048-3.pdfCitation Count: 65
-
OPENTitle: α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous systemJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 7Start Page: 739End Page: 746Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-012-0784-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-012-0784-0.pdfCitation Count: 71
- Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm2013OPENTitle: Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasmJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 9Start Page: 1345End Page: 1353Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-0998-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-0998-9.pdfCitation Count: 60
- Mentally stimulating activities associate with better cognitive performance in Parkinson disease2017OPENTitle: Mentally stimulating activities associate with better cognitive performance in Parkinson diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 124Issue #: 10Start Page: 1205End Page: 1212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-017-1761-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5693756Citation Count: 6
-
OPENTitle: The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and PosiphenJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 3Start Page: 493End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0513-5Citation Count: 69
-
OPENTitle: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 1Start Page: 23End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5Citation Count: 13
-
OPENTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Citation Count: 265
-
OPENTitle: Gender differences in cholinergic and dopaminergic deficits in Parkinson diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 10Start Page: 1421End Page: 1424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-013-1013-1Best OA location URL: http://doi.org/10.1007/s00702-013-1013-1Citation Count: 17
-
OPENTitle: In vitro high affinity α‐synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 4Start Page: 1428End Page: 1437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05245.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2008.05245.xCitation Count: 92
-
OPENTitle: Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brainJournal Name: Journal of NeurochemistryPublisher: WileyVol: 135Issue #: 6Start Page: 1242End Page: 1256Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/jnc.13369Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13369Citation Count: 66
-
OPENTitle: MKK6 binds and regulates expression of Parkinson’s disease‐related protein LRRK2Journal Name: Journal of NeurochemistryPublisher: WileyVol: 112Issue #: 6Start Page: 1593End Page: 1604Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06568.xBest OA location URL: http://doi.org/10.1111/j.1471-4159.2010.06568.xCitation Count: 100
-
OPENTitle: CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismJournal Name: Journal of NeurochemistryPublisher: WileyVol: 95Issue #: 4Start Page: 974End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2005.03428.xCitation Count: 284
-
OPENTitle: Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologiesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 109Issue #: 2Start Page: 623End Page: 630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.05996.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2009.05996.xCitation Count: 140
-
OPENTitle: Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress responseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 6Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07860.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2012.07860.x?download=trueCitation Count: 18
-
OPENTitle: VMAT2 and dopamine neuron loss in a primate model of Parkinson’s diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 1Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2007.05108.xBest OA location URL: http://doi.org/10.1111/j.1471-4159.2007.05108.xCitation Count: 117
-
OPENTitle: Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 111Issue #: 5Start Page: 1202End Page: 1212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.06404.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2009.06404.x?download=trueCitation Count: 58
-
OPENTitle: RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cellsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 2Start Page: 333End Page: 343Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07780.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3435458Citation Count: 38
-
OPENTitle: Parkin mediates the degradation‐independent ubiquitination of Hsp70Journal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1806End Page: 1819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05261.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4432938Citation Count: 99
-
OPENTitle: Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 100Issue #: 6Start Page: 1469End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2006.04333.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8669833Citation Count: 319
- CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease2012OPENTitle: CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 927End Page: 938Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11481-012-9402-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-012-9402-z.pdfCitation Count: 298
- Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.2006OPENTitle: Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 29End Page: 29Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1742-2094-3-29Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/1742-2094-3-29Citation Count: 136
-
OPENTitle: Up-regulation of BDNF in Astrocytes by TNF-α: A Case for the Neuroprotective Role of CytokineJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 212End Page: 222Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-006-9020-8Best OA location URL: http://doi.org/10.1007/s11481-006-9020-8Citation Count: 253
-
OPENTitle: Testing NF-κB-based Therapy in Hemiparkinsonian MonkeysJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 3Start Page: 544End Page: 556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-012-9377-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3419771Citation Count: 40
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 44
-
OPENTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2666445Citation Count: 47
-
OPENTitle: Using global statistical tests in long‐term Parkinson's disease clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 12Start Page: 1732End Page: 1739Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22645Best OA location URL: http://doi.org/10.1002/mds.22645Citation Count: 40
-
OPENTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: http://doi.org/10.1002/mds.22971Citation Count: 134
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 92
-
OPENTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 58
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8
-
OPENTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3154995Citation Count: 23
-
OPENTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3142314Citation Count: 19